[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Mexico Perennial Allergic Rhinitis Drug Market Research Report 2018

April 2018 | 103 pages | ID: M26D0C5B9DCEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Perennial Allergic Rhinitis Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Mexico plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Perennial Allergic Rhinitis Drug development status and future trend in Mexico, focuses on top players in Mexico, also splits Perennial Allergic Rhinitis Drug by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Mexico market include
  • Faes Farma, S.A.
  • Glenmark Pharmaceuticals Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Shionogi & Co., Ltd.
  • VentiRx Pharmaceuticals, Inc.
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • APC-3000
  • Asapiprant
  • Bilastine
  • Desloratadine
  • Others
On the basis of the end users/Application, this report covers
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Mexico Perennial Allergic Rhinitis Drug Market Research Report 2018

1 PERENNIAL ALLERGIC RHINITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Perennial Allergic Rhinitis Drug
1.2 Classification of Perennial Allergic Rhinitis Drug by Product Category
  1.2.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Market Share by Type in 2017
  1.2.3 APC-3000
  1.2.4 Asapiprant
  1.2.5 Bilastine
  1.2.6 Desloratadine
  1.2.7 Others
1.3 Mexico Perennial Allergic Rhinitis Drug Market by Application/End Users
  1.3.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Mexico Revenue and Sales of Perennial Allergic Rhinitis Drug (2013-2025)
  1.4.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.4.2 Mexico Perennial Allergic Rhinitis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 MEXICO PERENNIAL ALLERGIC RHINITIS DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Mexico Perennial Allergic Rhinitis Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Mexico Perennial Allergic Rhinitis Drug Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Mexico Perennial Allergic Rhinitis Drug Market Competitive Situation and Trends
  2.4.1 Mexico Perennial Allergic Rhinitis Drug Market Concentration Rate
  2.4.2 Mexico Perennial Allergic Rhinitis Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Mexico Market
2.5 Mexico Players/Manufacturers Perennial Allergic Rhinitis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 MEXICO PERENNIAL ALLERGIC RHINITIS DRUG SALES AND REVENUE (VALUE) BY TYPE (2013-2018)

3.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Mexico Perennial Allergic Rhinitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Mexico Perennial Allergic Rhinitis Drug Price (USD/Pcs) by Type (2013-2018)
3.4 Mexico Perennial Allergic Rhinitis Drug Sales Growth Rate (%) by Type (2013-2018)

4 MEXICO PERENNIAL ALLERGIC RHINITIS DRUG SALES BY APPLICATION (2013-2018)

4.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Mexico Perennial Allergic Rhinitis Drug Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 MEXICO PERENNIAL ALLERGIC RHINITIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

5.1 Faes Farma, S.A.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.1.2.1 Product A
    5.1.2.2 Product B
  5.1.3 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.1.4 Main Business/Business Overview
5.2 Glenmark Pharmaceuticals Ltd.
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.2.2.1 Product A
    5.2.2.2 Product B
  5.2.3 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.2.4 Main Business/Business Overview
5.3 Hisamitsu Pharmaceutical Co., Inc.
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.3.2.1 Product A
    5.3.2.2 Product B
  5.3.3 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.3.4 Main Business/Business Overview
5.4 Merck & Co., Inc.
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.4.2.1 Product A
    5.4.2.2 Product B
  5.4.3 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.4.4 Main Business/Business Overview
5.5 Pfizer Inc.
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.5.2.1 Product A
    5.5.2.2 Product B
  5.5.3 Pfizer Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.5.4 Main Business/Business Overview
5.6 Shionogi & Co., Ltd.
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.6.2.1 Product A
    5.6.2.2 Product B
  5.6.3 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.6.4 Main Business/Business Overview
5.7 VentiRx Pharmaceuticals, Inc.
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Perennial Allergic Rhinitis Drug Product Category, Application and Specification
    5.7.2.1 Product A
    5.7.2.2 Product B
  5.7.3 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.7.4 Main Business/Business Overview

6 PERENNIAL ALLERGIC RHINITIS DRUG MANUFACTURING COST ANALYSIS

6.1 Perennial Allergic Rhinitis Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Perennial Allergic Rhinitis Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Perennial Allergic Rhinitis Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Perennial Allergic Rhinitis Drug Major Manufacturers in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 MEXICO PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

10.1 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Mexico Market Size (Million USD) Status and Outlook (2013-2025)
Table Perennial Allergic Rhinitis Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Perennial Allergic Rhinitis Drug Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Perennial Allergic Rhinitis Drug
Table Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Volume Market Share by Type in 2017
Figure APC-3000 Product Picture
Figure Asapiprant Product Picture
Figure Bilastine Product Picture
Figure Desloratadine Product Picture
Figure Others Product Picture
Figure Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Comparison by Application (2013-2025)
Figure Mexico Sales Market Share (%) of Perennial Allergic Rhinitis Drug by Application in 2017
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Figure Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Mexico Perennial Allergic Rhinitis Drug Sales of Key Players/Manufacturers (2013-2018)
Table Mexico Perennial Allergic Rhinitis Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Mexico Perennial Allergic Rhinitis Drug Sales Share (%) by Players/Manufacturers
Figure 2017 Mexico Perennial Allergic Rhinitis Drug Sales Share (%) by Players/Manufacturers
Table Mexico Perennial Allergic Rhinitis Drug Revenue by Players/Manufacturers (2013-2018)
Table Mexico Perennial Allergic Rhinitis Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Mexico Perennial Allergic Rhinitis Drug Revenue Share (%) by Players/Manufacturers
Figure 2017 Mexico Perennial Allergic Rhinitis Drug Revenue Share (%) by Players/Manufacturers
Table Mexico Market Perennial Allergic Rhinitis Drug Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Mexico Market Perennial Allergic Rhinitis Drug Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Mexico Perennial Allergic Rhinitis Drug Market Share of Top 3 Players/Manufacturers
Figure Mexico Perennial Allergic Rhinitis Drug Market Share of Top 5 Players/Manufacturers
Table Mexico Players/Manufacturers Perennial Allergic Rhinitis Drug Manufacturing Base Distribution and Sales Area
Table Mexico Players/Manufacturers Perennial Allergic Rhinitis Drug Product Category
Table Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) by Type (2013-2018)
Table Mexico Perennial Allergic Rhinitis Drug Sales Share (%) by Type (2013-2018)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Share (%) by Type (2013-2018)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Market Share (%) by Type in 2017
Table Mexico Perennial Allergic Rhinitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Mexico Perennial Allergic Rhinitis Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Perennial Allergic Rhinitis Drug by Type (2013-2018)
Figure Revenue Market Share of Perennial Allergic Rhinitis Drug by Type in 2017
Table Mexico Perennial Allergic Rhinitis Drug Price (USD/Pcs) by Type (2013-2018)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Growth Rate (%) by Type (2013-2018)
Table Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) by Application (2013-2018)
Table Mexico Perennial Allergic Rhinitis Drug Sales Market Share (%) by Application (2013-2018)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Market Share (%) by Application (2013-2018)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Market Share (%) by Application in 2017
Table Mexico Perennial Allergic Rhinitis Drug Sales Growth Rate (%) by Application (2013-2018)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Growth Rate (%) by Application (2013-2018)
Table Faes Farma, S.A. Perennial Allergic Rhinitis Drug Basic Information List
Table Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure Faes Farma, S.A. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Basic Information List
Table Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Basic Information List
Table Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table Merck & Co., Inc. Perennial Allergic Rhinitis Drug Basic Information List
Table Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure Merck & Co., Inc. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table Pfizer Inc. Perennial Allergic Rhinitis Drug Basic Information List
Table Pfizer Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Pfizer Inc. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure Pfizer Inc. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Basic Information List
Table Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Basic Information List
Table VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales Market Share (%) in Mexico (2013-2018)
Figure VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Revenue Market Share (%) in Mexico (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Perennial Allergic Rhinitis Drug
Figure Manufacturing Process Analysis of Perennial Allergic Rhinitis Drug
Figure Perennial Allergic Rhinitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Perennial Allergic Rhinitis Drug Major Players/Manufacturers in 2017
Table Major Buyers of Perennial Allergic Rhinitis Drug
Table Distributors/Traders List
Figure Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Volume Market Share Forecast by Type in 2025
Table Mexico Perennial Allergic Rhinitis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure Mexico Perennial Allergic Rhinitis Drug Sales Volume Market Share Forecast by Application in 2025


More Publications